UV radiation-induced immunosuppression augments cutaneous carcinogenesis. The incidence of skin cancer continues to increase despite increased use of sunscreens, which are less effective at preventing immunosuppression than sunburn. Using the Mantoux reaction as a model of skin immunity, we investigated the effects of solar-simulated (ss) UV and its component UVA and UVB wavebands and tested the ability of topical nicotinamide to protect from UV-induced immunosuppression. Healthy, Mantoux-positive volunteers were UV-irradiated on their backs, with 5% nicotinamide or vehicle applied to different sites in a randomized, double-blinded manner. Subsequent Mantoux testing at irradiated and adjacent unirradiated sites enabled measurement of UV-induced immunosuppression with and without nicotinamide. Suberythemal ssUV caused significant immunosuppression, although component UVB and UVA doses delivered independently did not. Men were immunosuppressed by ssUV doses three times lower than those required to immunosuppress women. This may be an important cause of the higher skin cancer incidence and mortality observed in men. Topical nicotinamide prevented immunosuppression, with gene chip microarrays suggesting that the mechanisms of protection may include alterations in complement, energy metabolism and apoptosis pathways. Nicotinamide is a safe and inexpensive compound that could be added to sunscreens or after-sun lotions to improve protection from immunosuppression.
INTRODUCTION
Skin cancer is the most common form of malignancy in Caucasian populations (Diepgen and Mahler, 2002) . Immunosuppression enhances the development of skin cancers, as seen most dramatically in transplant recipients whose skin cancer risk is severalfold higher than that of the immunocompetent population (Bordea et al., 2004) . UV radiation in sunlight has profound immunosuppressive effects on the skin (Damian et al., 2001) , which play a central role in cutaneous carcinogenesis (Noonan et al., 2003; Ullrich, 2005) . The exact mechanisms of UV-induced immunosuppression, and the relative contribution of UVB (290-320 nm) and UVA (320-400 nm), are as yet unclear.
Various animal and human models of skin immunity have been used to demonstrate UV-induced immunosuppression in vivo. UV irradiation can impair both induction (primary sensitization) and elicitation of immune responses to cutaneous allergens (Damian et al., 2001; Wolf et al., 2003) . Systemic UV-induced immunosuppression can be measured following sensitization at a site distant from the irradiated field, whereas local immunosuppression is observed when antigen is applied at the site of UV exposure. Mantoux testing with tuberculin purified protein derivative (PPD) is used in clinical practice to assess tuberculosis immunity and exposure status. Mantoux-positive subjects, who have been either exposed to tuberculosis or vaccinated with Bacille Calmette-Guerin, develop localized induration and erythema 48-72 hours after intradermal injection of PPD. The diameter of induration can be measured clinically using the ''pen method'' whereby a ballpoint pen is used to mark the outer aspects of the Mantoux response (Bouros et al., 1991) . Erythema at reaction sites, assessed via reflectance spectrometry, provides a more sensitive measure of Mantoux intensity, which correlates well with the diameter of induration (Damian and Halliday, 2002) .
Men have both a higher incidence of and mortality from skin cancer (Foote et al., 2001; Molife et al., 2001) but the effect of gender on susceptibility to UV-induced immunosuppression in humans is unknown. Immunosuppression occurs with UV doses well below the sunburn threshold, and sunscreens may be less effective at preventing immunosuppression than sunburn (Damian et al., 1999; Poon et al., 2003) ; improved protection from the immune effects of UV is thus likely to reduce the incidence of malignant and premalignant skin lesions.
Nicotinamide, the active form of vitamin B 3 , is used clinically in the treatment of a variety of inflammatory skin disorders including bullous pemphigoid, acne, and rosacea (Niren, 2006) . Although the exact mechanism of action in these settings is unknown, nicotinamide is a known endogenous inhibitor of the nuclear enzyme poly-ADP-ribose polymerase (PARP), which regulates the expression of immunomodulatory proteins such as inducible nitric oxide synthase, intercellular adhesion molecule 1, major histocompatibility complex class II, and NF-kB (Virag and Szabo, 2002) .
Nicotinamide has also been shown to prevent UV-induced immunosuppression and carcinogenesis in mice (Gensler, 1997 (Gensler, , 1999 but its effects on UV immunosuppression in humans have not yet been investigated. We have previously shown that UV exposure attenuates Mantoux reactions in Bacille Calmette-Guerin-vaccinated volunteers (Damian et al., 1998; Friedmann et al., 2004) , and now report the effects of gender and nicotinamide on UV-induced suppression of the Mantoux reaction in humans.
RESULTS

Subjects
Of 75 people who started the protocol, 5 did not complete due to unrelated reasons. None of the subjects who completed the study were excluded from the results and none suffered significant adverse effects from the study. Table 1 shows the similar characteristics of volunteers who completed the various studies.
Mantoux-induced erythema increases in proportion to PPD dose
Although all subjects had initial Mantoux tests performed the week before UV irradiation, only 12 volunteers from various study groups were initially tested with the PPD dose combination of 1, 2, and 5 U ( Figure S1 ). The erythema index (EI) of subsequent Mantoux reactions was significantly correlated with PPD dose, as shown by a repeated measures linear regression (r ¼ 0.705, n ¼ 36, Po0.001).
UV irradiation did not cause systemic immunosuppression
The initial, pre-irradiation Mantoux tests (lateral lower back) were compared with those of unirradiated nicotinamideand vehicle-treated controls adjacent to the irradiated areas (medial lower back). Subjects were excluded from this analysis if initial PPD doses were different from those subsequently used. The mean EI of the initial Mantoux tests did not significantly differ from subsequent control tests in any of the groups. Therefore, solar-simulated (ss) UV, UVB, or UVA exposure did not cause systemic suppression of Mantoux reactions. Nicotinamide in the absence of UV had no immune effects in any study, as the EI of unirradiated control sites treated with nicotinamide did not differ from the EI of unirradiated initial or vehicle-treated sites. Similarly, there was no significant difference in the unirradiated control EI of men and women.
Topical 5% nicotinamide prevents ssUV-induced immunosuppression but not sunburn
The effect of 5% nicotinamide applied before ssUV exposure in 20 volunteers (10 men, 10 women) is shown in Figure 1a . The minimal erythema dose (MED) was unchanged by nicotinamide applied before or after ssUV exposure (Table 2 ; paired two-tailed Student's t-test). Mean erythema (EI) at vehicle-treated MED sites was not significantly different to the EI at the nicotinamide-treated site exposed to the same UV dose whether nicotinamide was applied before or after ssUV exposure. Hence, nicotinamide did not prevent sunburn. Spectrophotometry (Ultrospec 2100 pro UV/Visible Spectrophotometer, Biochrom Ltd, Cambridge, UK) of 5% nicotinamide in vehicle confirmed negligible absorption between 290 and 400 nm.
Men are more susceptible to ssUV-induced immunosuppression than women
To analyze the effects of gender, subjects from both ssUV studies, in which the irradiation protocols were identical, were combined. When the studies were analyzed separately, the results were similar and therefore we present the results of the combined studies only. Four subjects participated in both studies. One set of their results was therefore excluded, based on matching MEDs as evenly as possible for male and female volunteers. Four of the female volunteers were taking oral contraceptives, 5 were postmenopausal, and 9 were premenopausal. Because of the small numbers of women in each group, it was not possible to correlate hormonal status with susceptibility to immunosuppression.
When ssUV-induced immunosuppression at vehicle-treated sites was compared between men and women, men were significantly more immunosuppressed than women (repeated measures analysis of variance P ¼ 0.0224) and the threshold dose for immunosuppression was at least three times lower in men than women ( Figure 2 ). Among male volunteers, significant immunosuppression was observed at all doses of ssUV, whereas female volunteers were only significantly immunosuppressed by the highest dose. Although both men and women were significantly immunosuppressed by the highest ssUV dose, immunosuppression was 40% greater in men. Nicotinamide prevented suppression of Mantoux responses in both men and women (results not shown). In this combined group of volunteers, immunosuppression following exposure to the two highest ssUV doses correlated to MED (r ¼ À0.587, Po0.001 and r ¼ À0.353, Po0.05, respectively, using linear regression analysis); subjects who were more easily sunburned were also more susceptible to UV immunosuppression.
Component UVB and UVA doses were not independently immunosuppressive
The effect of irradiation with UVA or UVB alone on the Mantoux response was investigated in separate groups of 15 volunteers. Subjects were exposed to UVA or UVB on 3 consecutive days at doses equivalent to the UVA and UVB components of the previously used ssUV doses (0.75, 1.50, and 2.24 J/cm 2 of UVA and 0.075, 0.150, and 0.225 J/cm 2 of UVB). Comparison of Mantoux-induced erythema at irradiated and unirradiated sites showed no significant immunosuppression at any dose of UVB or UVA. Nicotinamide had no immune effects in this experiment ( Figure S2 ). 
UV Immunosuppression, Gender, and nicotinamide
Genes involved in complement, energy metabolism and apoptosis pathways are differentially regulated in vehicle-and nicotinamide-treated irradiated skin Six healthy volunteers (five men and one woman) were recruited for ssUV irradiation, biopsy, and microarray analysis. In each volunteer, two microarrays were compared and analyzed (vehicle-treated unirradiated vs vehicle-treated irradiated sites; and nicotinamide-treated unirradiated vs nicotinamide-treated irradiated sites). Results from one (male) volunteer were excluded because of technical inability to extract the microarray data due to inadequate hybridization.
Gene set enrichment analysis (GSEA) (false discovery rate p0.25, Po0.05) was applied to identify differentially regulated functional gene sets. In vehicle-treated skin, no significantly enriched pathways were upregulated by ssUV irradiation. Instead, a number of pathways were downregulated, including those relating to apoptosis (10 pathways), energy metabolism (5 pathways), and immune function including complement (4 pathways) (Tables S1 and  S2 ). Highly overlapping genes in apoptosis-related pathways were protein kinase C (PRKCA), cytochrome c (CYCS), insulin-like growth factor 1 receptor (IGF1R), BAD, BCL2, AKT1, caspase 3 (CASP3), HRAS, and TP53. In energy-related pathways, the leading edge subset of genes in the electron transport chain pathway (i.e., the genes most responsible for the enrichment signal) were mitochondrial ATP synthase (ATP5A1), succinate dehydrogenase complex subunits a and b (SDHA, SDHB), and cytochrome c (CYCS), which are key genes in energy production. In the citrate pathway, the nicotinamide adenine dinucleotide (NAD þ )-dependent enzymes isocitrate dehydrogenase (IDH1, IDH3B) and succinate-CoA ligase (SUCLG1, SUCLA2) were also downregulated. The leading edge subset of genes in complement pathways were C1Q, C1R, C1S, C4b, and C3. In nicotinamide-treated skin, significant downregulation of these pathways was no longer observed. Hence, nicotinamide inhibited ssUV-induced dysregulation of these genes.
In nicotinamide-treated irradiated skin, there was upregulation of the cadmium induces DNA synthesis and proliferation in macrophages (cdmac) pathway with leading edge subset genes comprising PLCB1, PRKCA, PRKCB1, HRAS, CUZD1, MAP2K1 (MEK1 or MKK1), MAPK3 (ERK1), TNF, and RELA. The histone deacetylase (hdac) pathway (involved in calcium regulation; McKinsey et al., 2000) was downregulated by ssUV in the presence of both vehicle and nicotinamide (leading edge genes in nicotinamide skin AKT1, CALM2, CAMK1, HDAC5, MEF2A, MEF2C, and NFATC2). Pathways for arginine and proline metabolism were also downregulated in nicotinamide-treated irradiated skin. The genes in these pathways, involved in energy metabolism such as providing precursors to the citrate cycle (Davis, 1986) were NOS3, GOT1, CKM, ASS, SMS, AMD1, CPS1, AOC3, OAT, and CKMT2.
DISCUSSION
Topical application of nicotinamide prevented UV-induced immunosuppression when applied either before or after UV exposure. The ssUV used in this study closely approximated the spectrum of natural sunlight, and was delivered at doses equivalent to those readily encountered on a daily basis. ssUV equivalent to 8 minutes of sun exposure (COLIPA, 1994) on 3 consecutive days caused more than 40% immunosuppression, and immunosuppression of 25% was caused by UV doses well below the average MED. Hence, significant immunosuppression occurred in the absence of sunburn.
Immunosuppression was prevented at all doses tested, with no adverse effects, when nicotinamide was applied In 20 volunteers, nicotinamide was applied 15 minutes before MED testing on one side of the back whereas at the same time base lotion was applied on the other side of the back. There was no significant difference between the mean MED (shown7SEM), nor in the mean EI at skin irradiated with one vehicletreated MED (EI at MED) between base lotion-treated sites and nicotinamide-treated sites. In 20 volunteers, nicotinamide was applied immediately after MED testing on one side of the back and base lotion was applied on the other side of the back. Again, there was no significant difference between the mean MED between base lotion-treated sites and nicotinamide-treated sites. before or after UV exposure. The protective effects of nicotinamide therefore do not result from sunscreening activity. This was confirmed by the lack of effect on MED and negligible UV absorbance by spectrophotometry. Although the baseline characteristics of the two ssUV groups were similar, the second group showed higher levels of immunosuppression. This is likely to reflect normal interindividual variation in susceptibility to UV-induced immunosuppression (Damian et al., 1998; Kelly et al., 2000) . Individuals who are more susceptible to UV-induced immunosuppression are at a greater risk of both melanoma and non-melanoma skin cancer (Yoshikawa et al., 1990) ; however, identifying these individuals is difficult as there are no clinically recognizable signs of cutaneous immunosuppression. As previously reported by Kelly et al. (2000) , we found that immunosuppression was significantly correlated to sunburn threshold; paler-skinned individuals were more susceptible to not only sunburn, but also UV immunosuppression.
We analyzed our microarray data using the innovative, supervised computational method GSEA (Subramanian et al., 2005) . Compared with unsupervised methods of analysis such as gene clustering and grouping based solely on gene expression, the pathway-oriented approach of GSEA is better able to detect relatively subtle differences between sample classes and examines entire pathways rather than single genes. For example, differential activity can be identified with a mean difference in gene expression of only 20% (Mootha et al., 2003) . Leading edge analysis, showing the gene sets most responsible for the enrichment signal, provided additional clues to identify the most critical subpathways.
Analysis of ssUV-regulated gene expression in vehicletreated human skin revealed several downregulated enriched biological pathways mainly related to complement, apoptosis, and energy metabolism. Complement has been shown to be involved early in the elicitation phase of DTH reactions in mice (Tsuji et al., 1997) , and is also known to be modulated by UV irradiation (Hammerberg et al., 1998) . In humans exposed to 3 MED of UVB, C3 activation was observed 3-12 hours after irradiation but not at later time points (Terui et al., 2001 ). In our study, there was downregulation of complement pathways in vehicle-treated skin, prevented by topical nicotinamide. It is possible that ssUV may have upregulated complement in vehicle-treated skin if biopsies were performed at an earlier time point, or in response to higher UV doses.
UV radiation-induced apoptosis is a protective response to cellular injury that removes potentially genetically damaged cells from the skin through the formation of sunburn cells (Melnikova and Ananthaswamy, 2005) , although imunohistochemistry of human skin irradiated with very low doses of ssUV (0.5-1 MED; within the range used in these studies) may not show any increase in apoptotic cell counts (Murphy et al., 2002) . Our gene array analysis of vehicle-treated skin showed ssUV-induced downregulation of the IGF-1R signaling pathway including the antiapoptotic genes IGF1R and AKT1. Also downregulated in vehicle-treated skin was the programmed cell death pathway, including the antiapoptotic gene BCL-2. Hence, ssUV exposure had proapoptotic effects in our transcriptional study. This is consistent with the results of Enk et al. (2006) , who used unsupervised gene clustering and functional grouping to report microarray findings in human skin irradiated in vivo with supraerythemal UVB doses (4 MED) . In contrast with our findings, Enk et al. (2006) found that UVB differentially regulated several pathways including those relating to S100 protein, serine protease inhibitors, and extracellular matrix factors such as metalloproteinases as well as apoptosis. This may reflect the much higher UV dose used. Nicotinamide prevented all of these effects. The apoptotic genes BCL2, TP53, IGF1R, PRKCA, and AKT1, comprising the leading edge subset of genes in the Tel pathway, are involved in regulation of telomerase activity, which enables the addition of telomeric repeats to telomeres and is thought to be involved in the early stages of cutaneous carcinogenesis (Ueda, 2000) . UV irradiation increases the rate of telomere shortening in skin cells (Kosmadaki and Gilchrest, 2004) , consistent with our findings that ssUV downregulated the telomerase pathway, and suggesting a protective effect of nicotinamide on this pathway.
Our observed downregulation of genes for energy production in several pathways in vehicle-treated, irradiated skin is consistent with ssUV-induced cellular energy depletion (Jacobsen et al., 2001) . This pathway was no longer downregulated in nicotinamide-treated skin, suggesting that nicotinamide induces changes in energy metabolism as well as apoptosis. Intracellular nicotinamide is metabolized to NAD þ , the essential coenzyme in ATP production and the sole substrate of the nuclear enzyme PARP (Hageman and Stierum, 2001) . PARP is involved in multiple cellular functions, including regulation of p53 expression (Wieler et al., 2003) , and is rapidly activated in response to DNA damage. Although modest PARP activation enhances DNA repair, overactivation can cause cell death. Nicotinamide is an endogenous PARP inhibitor (Hageman and Stierum, 2001) ; hence PARP inhibition by nicotinamide may have reduced cellular damage. Like Enk et al. (2006) , we found that ssUV downregulated p53, whereas in the presence of nicotinamide, p53 downregulation was prevented. Nicotinamide has also been shown to alter p53 regulation directly, independent of PARP (McLure et al., 2004) .
The gene expression profile of nicotinamide-treated, irradiated skin showed upregulation of the enriched pathway cdmac, which includes genes that overlap with UVA-induced ERK activation (protein kinase C; PRKCA, PRKCB1, phospholipase C, RAS and the extracellular signal-regulated kinases 1 and 2, ERK, or MAPK3) (He et al., 2004) . Direct NADH insertion is known to increase intracellular calcium (Kaplin et al., 1996) . Phospholipase activation and calcium increase are required for ERK activation, which plays an important role in cell proliferation and differentiation. It is possible that a nicotinamide-induced increase in intracellular calcium might be an essential upstream signal regulator for the ERK activation (He et al., 2004) .
For the first time, we have shown that ssUV-induced immunosuppression is greater in men. Only the highest ssUV www.jidonline.org 451 dose caused significant immunosuppression in female volunteers. In contrast, men were significantly immunosuppressed by ssUV doses three times less than the sunburn threshold, and were more immunosuppressed than women at all doses tested. Male and female volunteers were well matched for MED and skin color and were of similar ages. The incidence of smoking, which not only suppresses systemic immunity but is also associated with cutaneous squamous-cell carcinoma (Freiman et al., 2004) , was the same in men and women as was previous history of skin cancer. Hence, these factors were not a cause of greater immunosuppression in men.
Similar findings have been reported in mice, where UVBinduced immunosuppression was significantly greater in male than in female mice and this was reversed by injecting males with 17-b-estradiol before irradiation (Hiramoto et al., 2004) . In female mice, ssUV-induced immunosuppression was exacerbated by topical application of an estrogen receptor antagonist and attenuated by topical 17-b-estradiol (Widyarini et al., 2006) . Immune cells such as lymphocytes and macrophages are known to bear sex steroid receptors, which implies that estrogen may influence cytokine production by these cells (Kovacs and Messingham, 2002) . Male gender is an independent risk factor for immunosuppression following surgical procedures (Wichmann et al., 2003) , and murine studies suggest that testosterone is responsible (Wichmann et al., 1996) . Our findings may explain the higher female incidence of cutaneous disorders such as polymorphous light eruption (Mastalier et al., 1998) , as well as the greater skin cancer incidence and mortality observed in men (Foote et al., 2001; Molife et al., 2001) .
In our study, low doses of ssUV (UVA þ UVB) were immunosuppressive but when the UVA and UVB components of various ssUV doses were studied individually, we found that neither UVA alone nor UVB alone was immunosuppressive. This suggests that at the very low UV doses used here, an interaction between the effects of UVA and UVB leads to immunosuppression, as has been described in studies of ssUV-induced suppression of contact hypersensitivity to nickel in nickel-allergic volunteers (Poon et al., 2005) . Immunosuppressive effects may have been detected with higher individual component doses of UVA and UVB.
In conclusion, we have shown that a likely interactive effect of UVB and UVA produces ssUV-induced immunosuppression at doses well below the sunburn threshold, and that men are far more susceptible to this immunosuppression than women. Nicotinamide appeared to mediate its immuno protective effects by preventing ssUV-induced changes in complement, apoptosis, and cellular energy pathways, consistent with its known roles as a PARP inhibitor, ATP precursor, and anti-inflammatory agent. Nicotinamide also influenced ssUV-induced transcriptional regulation of genes in the cdmac and arginine catabolic pathways. Whether this novel finding is related to the protective effects of nicotinamide on the skin requires further investigation with functional studies. Skin cancer incidence is rising and sunscreens can be improved by ensuring protection from immunosuppression as well as sunburn.
MATERIALS AND METHODS
Participants
Healthy Mantoux-positive volunteers who had previously been vaccinated with BCG were recruited and were required to cease any vitamin supplementation and avoid sun exposure on their back at least 4 weeks before and during the study. The study was conducted according to the Declaration of Helsinki Principles, and approval was obtained from the Sydney University and Central Sydney Area Health Service Ethics Committees. All volunteers provided written informed consent before inclusion.
Study techniques
The UV source, described in detail previously (Damian and Halliday, 2002) , was a 1,000 W xenon arc solar simulator (Oriel, Stratford, CT), filtered to attenuate visible and infrared wavelengths, remove UVC (o290 nm), and modify the spectral output so that it simulated sunlight (ssUV), or comprised predominantly UVB or UVA only (Damian and Halliday, 2002) . Spectra were measured at 1 nm intervals with an OL754 spectroradiometer (Optronics, Orlando, FL), which had been calibrated with standard lamps. An IL-1350 broadband radiometer with interchangeable UVA (SED 038) and UVB (SED 240) detectors (International Light, Newburyport, MA) was calibrated against the source using the spectroradiometer and this was used to enable rapid measurement of irradiance before each irradiation.
One week before irradiation, volunteers were tested with three different concentrations of tuberculin PPD (CSL Limited, Parkville, Victoria, Australia), diluted in 0.9% normal saline to a volume of 0.05 ml and injected intradermally on the lower back to confirm positivity and allow selection of the most appropriate PPD dose for further testing in each volunteer. Different PPD dose ranges were used depending on the subjects' previous reactivity. The intensity of subsequent Mantoux reactions was assessed 72 hours after injection using the ''pen method'' for measuring Mantoux diameter (Bouros et al., 1991) . Only participants with a Mantoux diameter X4 mm were eligible for the study. Mantoux reactions were also measured with a reflectance erythema meter (Diastron, Hampshire, UK), which we have previously found to provide a more sensitive and reliable measure of changes in skin immunity than diameter (Damian et al., 1998; Friedmann et al., 2004) . Erythema induced by PPD was calculated as the difference between the EI of the Mantoux response and the EI of adjacent skin. Erythema meter readings were taken in triplicate and an average EI for each site was recorded.
Nicotinamide (Fluka Chemie AG, Buchs, Switzerland) was prepared in 1:2:1 propylene glycol, ethanol, and distilled water vehicle at a concentration of 5%. The clear, colorless solutions, prepared fortnightly in our laboratory, were applied (2 ml/ cm 2 )
topically to test sites on the mid-to lower back in a randomized, double-blinded manner. Subjects were asked to avoid washing the test sites for at least 8 hours after each application.
Study design
The week after initial Mantoux testing, separate 2.0 Â 2.5 cm areas on each side of the lower back were irradiated with one of three fixed doses of ssUV (0.74, 1.48, and 2.22 J/cm 2 ) daily for 3 consecutive days. Adjacent, unirradiated sites on each side served as immunologically intact controls. Nicotinamide lotion was applied to test sites on one side of the back, and vehicle to the opposite side, 15 minutes before or immediately after each ssUV exposure in separate studies. Mantoux tests were performed at irradiated and unirradiated sites immediately after the final irradiation and measured 72 hours later. Each volunteer's MED or sunburn susceptibility was determined by exposing ten 1 cm squares on the upper back to graded ssUV doses and noting the dose that caused threshold erythema 24 hours later. The effects of nicotinamide and vehicle on MED were assessed in all subjects both visually and with the erythema meter. A separate melanin index function in the erythema meter was used to measure the skin color of the mid-back.
Additional groups of Mantoux-positive volunteers were recruited to assess the immune effects of UVB and UVA doses approximating those contained within the ssUV doses, with nicotinamide applied to one side of the back and vehicle to the other immediately after irradiation as described above.
Microarray study
To investigate possible mechanisms of the immune effects of ssUV and nicotinamide, six volunteers were irradiated with a single, fixed dose of ssUV (2.22 J/cm 2 ; B0.5 average MED of this group) onto two areas of their lower backs. These sites were treated with nicotinamide or vehicle immediately after irradiation, as were two adjacent, unirradiated sites. Nicotinamide was applied after irradiation to exclude completely any theoretical possibility of a sunscreening effect of nicotinamide. Twenty-four hours later, a 3 mm punch biopsy was taken from each of the four sites. Total RNA was extracted using TRIzol reagent (Gibco Invitrogen Life Technologies, Carlsbad, CA), purified and DNase-treated using the RNeasy Fibrous Tissue Mini Kit (Qiagen Sciences, Valencia, CA), and amplified using the MessageAmp II aRNA Kit (Ambion Inc., Austin, TX). Total RNA (60-70 mg) was then reverse-transcribed into cDNA with direct incorporation of cyanine 3-dCTP and cyanine 5-dCTP fluorescent dyes (Perkin Elmer Life Sciences, Boston, MA). Following hybridization onto Compugen 19,000 human oligonucleotide microarray slides (Adelaide Microarray Facility, The University of Adelaide, Australia), microarrays were scanned using an Axon scanner (Axon Instruments, Sunnyvale, CA) with GenePix Pro 5.0 software.
Preprocessing and normalization were applied to all microarray expression data before the assessment of differential gene expression, using GSEA methodology (Subramanian et al., 2005) . To input microarray data into GSEA, the accession numbers from the microarrays of normalized treated groups were mapped to corresponding gene symbols using the EASE software in the Database for Annotation, Visualization, and Integration Discovery (DAVID) Hosack et al., 2003) . GSEA was performed as previously described using a C2 human-specific gene set library containing 522 gene sets whose products are involved in specific metabolic and signaling pathways (Subramanian et al., 2005) . We used the default setting signal-to-noise ranking metric in GSEA to rank genes. The statistical significance (P-value) of each pathway was estimated by using phenotype-based permutation estimation using 1,000 random permutations. We chose pathways with a significant enrichment score (Po0.05) that had been adjusted for multiple comparisons using the false discovery rate (qo0.25) for further interpretation. The false discovery rate is a quantity that describes for a set of tests that are deemed significant at or below a given level what proportion of them are likely to be false-positive findings (Storey and Tibshirani, 2003) .
Statistical analysis
Immunosuppression at each site (DEI) was calculated as the difference between the EI of unirradiated control sites and the EI of irradiated test sites. Statistical comparisons were made using paired two-tailed Student's t-tests, with DEI considered significant if Po0.05 following Bonferroni correction. All data sets in the immunosuppression and MED experiments showed normal distribution (Kolmogorov-Smirnov test).
Results are presented as mean7SEM. We analyzed intervention and immunosuppression using repeated measures analysis of variance. Correlations were performed using linear regression analysis or repeated measures linear regression (a random intercept linear mixed model fitted using STATA v 9.2) as stated.
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